Venous thromboembolism is a complex, multifactorial disorder, the pathogenesis of which typically involves a variety of inherited or acquired factors. The multifactorial etiology of this disease ...
BACKGROUND: Both unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial.
Early increases in CRP during immune checkpoint inhibitor (ICI) therapy are linked to a higher risk of venous thromboembolism (VTE). CRP trajectories could serve as biomarkers for assessing VTE risk ...
CT neck showed focal nodular thickening in the left false vocal cord and thrombus in the right main pulmonary artery. The subsequent CT pulmonary angiogram performed revealed right pulmonary ...
Obesity is a recognized risk factor for venous thromboembolism (VTE), associated with distinct challenges in managing anticoagulation therapy. There is still limited evidence regarding the impact of ...
Blood clots in deep veins, collectively known as venous thromboembolism (VTE), include deep vein thrombosis, which occurs when a blood clot forms in a deep vein of the legs, arms, or an internal organ ...
Panelists discuss how venous thromboembolism risk assessment and prophylaxis decisions in patients with non–small cell lung cancer require careful consideration of individual risk factors, patient ...